Objective The multinational ERYTHRO ( NCT06046534) study investigated the experience of patients with moderate-to-severe SLE ...
Patients with systemic lupus erythematosus have higher risks for mortality and complications than control individuals; Black ...
Systemic lupus erythematosus (SLE) is characterized by autoantibody production, with anti-dsDNA antibodies (anti-dsDNA) being a key indicator for SLE diagnosis and disease monitoring. A new study ...
For the patient who presents with a new diagnosis of SLE, or for the one who has a flare in previously established disease, the immediate need is to achieve control of the inflammatory process. In ...
Objective Cardiovascular diseases are a leading cause of morbidity and mortality in SLE. In this target population, ...
AMPEL BioSolutions announced the launch of LuGENE®, an exciting breakthrough innovation in systematic lupus erythematosus (SLE) care. LuGENE® is a new blood test designed to predict SLE flares before ...
The European Alliance of Associations for Rheumatology has published new recommendations on core datasets to be used in systemic lupus erythematosus (SLE). The work defines a set of essential items ...
Credit: Getty Images Understanding the underlying mechanisms and immunological dysfunction of SLE is essential to appreciate its diverse clinical manifestations and guide effective diagnosis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results